Displaying results 157 - 168 of 241
General Hepatology
Clinical superior applicability and repeatability of Hepatoscope 2DTE thanks to imaging-related criteria

Clinical superior applicability and repeatability of Hepatoscope 2DTE thanks to imaging-related criteria

ePosters
View
General Hepatology
Hormetic effects of 7-Ketocholesterol in preventing ferroptosis-induced hepatocyte death

Hormetic effects of 7-Ketocholesterol in preventing ferroptosis-induced hepatocyte death

ePosters
View
General Hepatology
Alcohol and metabolic factors influence steatotic liver disease clinical outcomes

Alcohol and metabolic factors influence steatotic liver disease clinical outcomes

ePosters
View
General Hepatology

Occupational and environmental exposures in liver disease

Webcasts
View

test delegates and easl membership 16 jan

Webcasts
View
Viral Hepatitis
EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio
View
Rare Liver Diseases
EASL Policy Dialogues S3 E5: Enhancing treatment adherence & quality of life in rare liver disease

EASL Policy Dialogues S3 E5: Enhancing treatment adherence & quality of life in rare liver disease

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - FR

PDF
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - GE

PDF
View
Public Health and Advocacy
EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

EASL Policy Statement on the Coexistence of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease - CZ

PDF
View
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - GE

EASL Policy Statement on Hepatitis C Elimination - GE

PDF
View
Public Health and Advocacy
EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

EASL Policy Statement on Drug Use and the Global Hepatitis C Elimination Goal - RU

PDF
View